Perth Blood Institute

West Perth 6005

1 studies enrolling now · 3 studies all time

What they study most

Acute Myeloid Leukemia (AML), Secondary to Myeloproliferative Neoplasms (MPN), Anemia, Multiple Myeloma, Myelodysplastic Syndromes, Myelofibrosis, Myelofibrosis Due to and Following Polycythemia Vera, Myelofibrosis; Anemia, Post-essential Thrombocythemia Myelofibrosis, Primary Myelofibrosis, Relapsed or Refractory Acute Myeloid Leukemia (AML)

Studies at this site

• Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia — Recruiting now
• A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and Lenalidomide — Running, not enrolling
• An Open-Label, Multicenter, Phase 1b/2 Study of the Safety and Efficacy of KRT-232 When Administered Alone and in Combination With Low-Dose Cytarabine (LDAC) or Decitabine in Patients With Acute Myeloid Leukemia (AML) — Stopped early